EGFR and non-small cell lung carcinoma: Our study revealed that seven kinases, CTNNB1, CRK, EGFR, ERBB2, PIK3R1, PLCG1, and PTPN11, were highly activated in all NSCLC patients harboring sensitizing EGFR mutations.